Fox Chase Cancer Center’s Dr. Sameer Patel Named Vice President of the Robert H. Ivy Society of Plastic Surgeons

Dr. patel
Sameer Patel, MD, FACS, Chief of Plastic and Reconstructive Surgery at Fox Chase, was recently named Vice President of the Robert H. Ivy Society of Plastic Surgeons.

PHILADELPHIA (May 15, 2024) — Sameer Patel, MD, FACS, Chief of Plastic and Reconstructive Surgery at Fox Chase Cancer Center, was recently named Vice President of the Robert H. Ivy Society of Plastic Surgeons. 

The society, which was formed in 1954, works to ensure a continued high standard of clinical practice in plastic surgery, as well as to promote medical and surgical research. Additionally, the society provides a medium for the exchange of information relating to plastic, aesthetic, and reconstructive surgery. 

“The Robert H. Ivy Society is a pillar of excellence in promoting high ethical standards of surgical practice and engaging esteemed surgeons in continued education in the field,” said Patel. “Serving as Vice President is an incredible honor, and I am eager to play a pivotal role in highlighting the importance of the social, economic, and psychological aspects of this specialty.” 

Patel was elected Vice President for the 2024-2025 board year at the society’s annual business meeting in March. The Vice President serves as the chair of the Program Committee, which will plan the 71st Annual Scientific Meeting that will occur next spring. He also serves as a voting board member for the society. 

In addition to his role as Chief of Plastic and Reconstructive Surgery, Patel is also an Associate Professor in the the Department of Surgical Oncology at Fox Chase. In addition to being a member of the National Comprehensive Cancer Center Network Breast Cancer Panel, Patel is a member of the American Society of Reconstructive Microsurgery and the American Association of Plastic Surgeons. He has also been named a Top Doctor by Philadelphia magazine for both 2023 and 2024. 

In addition to performing surgery, Patel studies surgical outcomes of head and neck cancer patients to find new ways of maximizing function and improving appearance, including the use of advanced computer-aided, patient-specific surgical planning techniques. He also gathers research data on breast reconstruction procedures to determine which options may be best for different types of patients.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427